Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Next Generation Sequencing to Detect Borrelia Burgdorferi DNA in the Blood of Pediatric Patients With Lyme Disease

NCT03505879 is registered in ClinicalTrials.gov with Stony Brook University as lead sponsor.

NCT NCT03505879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03505879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Next Generation Sequencing to Detect Borrelia Burgdorferi DNA in the Blood of Pediatric Patients With Lyme Disease
Lead sponsor
Stony Brook University
Phase
Observational
Overall status
Completed
Start date
July 24, 2018
Completion date
May 31, 2020
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erythema migrans, lyme arthritis, lyme carditis, lyme disease, lyme disease meningitis, pediatric infectious disease